Lastly, we tested the feasibility of small molecule inhibitors that specifically target hyperactive rRNA synthesis and augmented protein translation suppressing growth and elevated expression of MYC family proteins in unfavorable neuroblastoma cells. This evidence concerns the gene MYC and neuroblastoma.